Kuwait Medical Electronic Library

Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait

Abdullah Albassam 1, Shahad Alshammari 2, Ghadeer Ouda 3, Samuel Koshy 1, Abdelmoneim Awad 1

Affiliations

expand

05 September 2018

doi: 10.1371/journal.pone.0203033

Abstract

Background: Pharmacogenetics practice has been successfully implemented in many developed countries to enhance personalized medicine and improve clinical and economic outcomes. An understanding of healthcare providers' knowledge, perceptions, confidence towards pharmacogenetics, and their active enrollment with pharmacogenetic testing is essential for test acceptance and utilization. This study was designed to assess physicians' and pharmacists' knowledge, perceptions, and confidence towards pharmacogenetics, determine the preferred learning format for their future education in pharmacogenetics, and identify the barriers to its application in their practice settings.

Methods: A cross-sectional survey was conducted using a pretested self-administered questionnaire on a sample of 629 randomly selected physicians and pharmacists. Descriptive and comparative analyses were used in data analysis.

Results: The response rate was 98.1%. Less than one-tenth of respondents were exposed to pharmacogenetics education or training (8.9%), applied pharmacogenetics testing in their practice (9.4%), or provided patient counselling on the results of the pharmacogenetic testing (9.1%), and over 90% of them were physicians. The overall respondents' mean (SD) total knowledge score percentage was low [45.0% (24)] and there was no significant difference between the physicians and pharmacists scores (p>0.05). Only 16.0% of participants indicated that they felt confident in applying pharmacogenetics in their practice settings. Despite these low levels of knowledge and self-confidence, 70.2% of participants expressed overall positive perceptions towards pharmacogenetics and its clinical implications. These positive overall perceptions were found to be significantly more common among pharmacists compared to physicians (p<0.05). The top two perceived barriers facing the implementation of pharmacogenetics in Kuwait were lack of education or training and clinical guidelines.

Conclusions: These findings highlight important concerns and will aid in the assessment of current pharmacogenetics practice. Also, they will provide further insight in designing future targeted multifaceted interventions to promote the adoption and utilization of pharmacogenetics testing in Kuwait.

Figures

Fig 1. Respondents’ educational format preferences in pharmacogenetics.

Fig 2. Perceived barriers facing the implementation of pharmacogenetic testing in clinical practice.

Cited by

Knowledge, attitudes, and perceptions of the multi-ethnic population of the United Arab Emirates on genomic medicine and genetic testing.

Rahma AT, Ali BR, Patrinos GP, Ahmed LA, Elbarazi I, Abdullahi AS, Elsheik M, Abbas M, Afandi F, Alnaqbi A, Al Maskari F.Hum Genomics. 2023 Jul 15;17(1):63. doi: 10.1186/s40246-023-00509-0.PMID: 37454085 Free PMC article.

An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students.

Mehtar M, Hammoud SH, Amin MEK.Saudi Pharm J. 2022 Dec;30(12):1765-1772. doi: 10.1016/j.jsps.2022.10.005. Epub 2022 Oct 12.PMID: 36601506 Free PMC article.

Physicians' Knowledge, Attitude, and Experience of Pharmacogenomic Testing in China.

Jia T, Wu C, Hu X, Li S, Zhang X, Cai Y, Chen J, Shi L, Lu CY, Nie X.J Pers Med. 2022 Dec 7;12(12):2021. doi: 10.3390/jpm12122021.PMID: 36556242 Free PMC article.

Clinicians' Perceptions towards Precision Medicine Tools for Cardiovascular Disease Risk Stratification in South Africa.

Kamp M, Pain O, May A, Lewis CM, Ramsay M.J Pers Med. 2022 Aug 24;12(9):1360. doi: 10.3390/jpm12091360.PMID: 36143145 Free PMC article.

Clinical Pharmacists' Knowledge of and Attitudes toward Pharmacogenomic Testing in China.

Nie X, Jia T, Hu X, Li S, Zhang X, Wu C, Zhang Y, Chen J, Shi L, Lu CY.J Pers Med. 2022 Aug 21;12(8):1348. doi: 10.3390/jpm12081348.PMID: 36013297 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

1. US National Library of Medicine. Genomic Research: What is Pharmacogenetics [Internet]. 2018 [cited 2018 Mar 21]. Available from: https://ghr.nlm.nih.gov/primer/genomicresearch/pharmacogenetics
1. Dunnenberger H, Crews K, Hoffman J, Caudle K, Broeckel U, Howard S, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol. 2015;55: 89–106. 10.1146/annurev-pharmtox-010814-124835 - DOI - PMC - PubMed
1. John SE, Antony D, Eaaswarkhanth M, Hebbar P, Alkayal F, Tuomilehto J, et al. Genetic variants associated with warfarin dosage in Kuwaiti population. Pharmacogenomics. 2017;18: 757–764. 10.2217/pgs-2017-0020 - DOI - PubMed
1. Alrashid MH, Al-Serri A, Alshemmari SH, Koshi P, Al-Bustan SA. Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals. Mol Diagnosis Ther. 2016;20:183–90. - PubMed
1. Pathare A V., Zadjali S Al, Misquith R, Alkindi SS, Panjwani V, Lapoumeroulie C, et al. Warfarin Pharmacogenetics: Polymorphisms of the CYP2C9, CYP4F2, and VKORC1 Loci in a Genetically Admixed Omani Population. Hum Biol. 2012;84: 67–77. 10.3378/027.084.0103 - DOI - PubMed
1. Sivadas A, Sharma P, Scaria V. Landscape of warfarin and clopidogrel pharmacogenetic variants in Qatari population from whole exome datasets. Pharmacogenomics. 2016;17:1891–1901. - PubMed
1. Tuteja S, Haynes K, Zayac C, Sprague J, Bernhardt B, Pyeritz R. Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Per Med. 2013;10:793–800. 10.2217/pme.13.85 - DOI - PMC - PubMed
1. Martin MA, Kroetz DL. Abacavir pharmacogenetics—from initial reports to standard of care. Pharmacotherapy. 2013;33: 765–775. 10.1002/phar.1278 - DOI - PMC - PubMed
1. Annis DS, Mosher DF, Roberts DD. Pharmacoginetics in clinical practice: how far have we come and where are we going? Pharmacogenomics. 2009;27: 339–351.
1. Chen P, Lin J, Lu C, Ong C, Hsieh P, Yang C, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011;364: 1126–1133. 10.1056/NEJMoa1009717 - DOI - PubMed
1. US Food and Drug Administration. Table of Pharmacogenetics Biomarkers in Drug Labeling [Internet]. [cited 2018 Mar 21]. Available from: https://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics...
1. Peterson J, Field J, Shi Y. Attitudes of clinicians following large-scale pharmacogenetics implementation. Pharmacogenomics J. 2016;16: 393–398. 10.1038/tpj.2015.57 - DOI - PMC - PubMed
1. Streetman D. Emergence and evolution of pharmacogenetics and pharmacogenetics in clinical pharmacy over the past 40 years. Ann Pharmacother. 2007;41:2038–2041. 10.1345/aph.1K273 - DOI - PubMed
1. Frick A, Benton C, Scolaro K. Transitioning Pharmacogenetics into the Clinical Setting: Training Future Pharmacists. Front Pharmacol. 2016;7: 241 10.3389/fphar.2016.00241 - DOI - PMC - PubMed
1. Mose B, Kim R. Is personalized medicine a dream or a reality. Crit Rev Clin Lab Sci. 2015;52(1):1–11. 10.3109/10408363.2014.950407 - DOI - PubMed
1. Yau A. Knowledge, attitude and practice concerning pharmacogenetics among pharmacists: A systematic Review. J Young Pharm. 2015;7: 145–154.
1. Owusu-Obeng A, Weitzel K, Hatton R, Staley B, Ashton J, Cooper-Dehoff R, et al. Emerging roles of pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy. 2014;34: 1102–1112. 10.1002/phar.1481 - DOI - PMC - PubMed
1. Nutescu E, Drozda K, Bress A. Feasibility of implementing a comprehensive warfarin pharmacogenetics service. Pharmacotherapy. 2013;33: 1156–1164. 10.1002/phar.1329 - DOI - PMC - PubMed
1. McCullough K, Formea C, Berg K, Burzynski J, Cunningham J, Ou N, et al. Assessment of the pharmacogenetics educational needs of pharmacists. Am J Pharm Educ. 2011;75: 51 - PMC - PubMed
1. Stanek E, Sanders C, Taber K, Khalid M, Patel A, Verbrugge R, et al. Adoption of pharmacogenetics testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91: 450–458. 10.1038/clpt.2011.306 - DOI - PubMed
1. Salm M, Abbate K, Appelbaum P, Ottman R, Chung W, Marder K, et al. Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training. J Genet Couseling. 2014;23: 156–63. - PMC - PubMed
1. Klitzman R, Chung W, Marder K, Shanmugham A, Chin L, Stark M, et al. Attitudes and practices among internists concerning genetic testing. J Genet Couns. 2013;22: 90–100. 10.1007/s10897-012-9504-z - DOI - PMC - PubMed
1. Muzoriana N, Gavi S, Nembaware V, Dhoro M, Matimba A. Knowledge, attitude, and perceptions of pharmacists and pharmacy students towards pharmacopgenomics in Zimbabwe. Pharmacy. 2017;5: 1–10. - PMC - PubMed
1. Elewa H, Alkhiyami D, Alsahan D. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenetics and its challenges in Qatar. J Eval Clin Pract. 2015;21: 703–709. 10.1111/jep.12372 - DOI - PubMed
1. World Health Organization. Statistics [Internet]. 2018 [cited 2018 Mar 21]. Available from: http://www.who.int/countries/kwt/en/
1. Raosoft. Sample Size Calculator [Internet]. [cited 2018 Mar 21]. Available from: http://www.raosoft.com/samplesize.html
1. World Health Organization. How to investigate drug use in health facilities: Selected drug use indicators. 1993.
1. Bannur Z, Bahaman S, Salleh M, Kek T. Pharmacogenetics based practice in Malaysia: The attitude, knowledge and adoption by the healthcare professionals. Int Med J Malaysia. 2014;13: 41–50.
1. Katoue M, Awad A, Schwinghammer T, Kombian S. Pharmaeutical care in Kuwait: hospital pharmacists’ perspectives. Pharm Pract (Granada). 2014;36: 1170–1178. - PubMed
1. Springer J, Iannotti N, Kane M, Haynes K, Sprague J. Pharmacogenetics training using an instructional software system. Am J Pharm Educ. 2011;75: 32 - PMC - PubMed
1. Stanford University & St. Jude Children’s Research Hospital. The Clinical Pharmacogenetics Implementation Consortium (CPIC) [Internet]. 2018 [cited 2018 May 25]. Available from: https://cpicpgx.org/
1. Mills R, Haga S. Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counsellors and pharmacists. Pharmacogenetics. 2013;14: 957–968. - PMC - PubMed
1. Williams M. Genomic medicine implementation: learning by example. Am J Med Genet. 2014;166: 8–14. - PubMed
1. Green J, O’Brien T, Chiappinelli V, Harralson A. Pharmacogenetics instruction in US and Canadian medical schools: implications for personalized medicine. Pharmacogenomics. 2010;11: 1331–1340. 10.2217/pgs.10.122 - DOI - PubMed
1. Patrinos G, Katsila T. Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece. Pharmacogenomics. 2016;17: 1865–1872.
1. Zembles T. An inservice program on pharmacogenetics to individualize drug therapy. Am J Pharm Educ. 2010;74:10 - PMC - PubMed
1. Kuo G, Ma J, Lee K, Halpert J, Bourne P, Ganiats T, et al. Institutional Profile: University of California San Diego Pharmacogenetics Education Program (PharmGenEdTM): bridging the gap between science and practice. Pharmacogenomics. 2011;12: 149–53. 10.2217/pgs.10.213 - DOI - PubMed

Show All